Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- Comcast Boosts Stock Buyback Nearly 60% After Time Warner Cable Deal Bust also written by Antoine Gara
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- DuPont Spinoff Fans Flames In Trian Management's Scorched Earth Fight also written by Antoine Gara
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- No Sleep Till Activism: Hedge Fund H Partners Wins Mattress Company Fight also written by Antoine Gara
Login to comment.